A bovine ovarian polypeptide fraction in the Khavinson reproductive shelf, with sparse named-product literature and denser adjacency in light-cycle and embryo work.
Bioregulator · Khavinson school · bovine ovarian polypeptide fraction
polypeptide fraction · bovine ovary
identity
fraction
bovine ovarian polypeptide fraction
labelovagen|linebioregulator|schoolKhavinson
Tissue-specific reproductive bioregulator frame. Dedicated Ovagen product monographs are sparse in our map.
Archive identity for a polypeptide fraction. Mixture of sequences.
Key takeaways
Ovagen is framed as a bovine ovarian polypeptide fraction in the Khavinson reproductive bioregulator shelf.
Dedicated product literature is sparse. Mapped Russian rows are mostly adjacency: constant-light anovulation risk, melatonin in obstetrics, goat polyovulation / embryo transfer, and organotypic ovary culture peptide complexes.
This page records a thin named-product trail honestly.
What it is
Ovagen sits as an ovarian-tissue cytomedin neighbour to other reproductive fractions on this shelf.
School concept language for ovarian peptide bioregulation is established; open dedicated Ovagen® pharmacology is under-published in our CyberLeninka audit.
We keep it so reproductive shelf gaps stay visible beside denser products such as prostatilen.
What the literature describes
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Light regime and reproductive-axis adjacency
Russian titles on constant light, anovulation and female reproductive cancer risk, plus melatonin in obstetric-gynaecological practice, sit in the pineal-ovarian neighbourhood that school writing links to ovarian peptide concepts.
Agricultural reproduction titles on goat polyovulation induction, embryo cryoresistance and transplant schemes often mention peptide combinations. Synthesis treats these as paradigm adjacency. They are not Ovagen product trials.
Titles on polypeptide complexes in organotypic ovary tissue culture and medicinal peptide preparations give the closest laboratory neighbourhood to an ovarian cytomedin frame.
Named Ovagen density is low. Light-axis, melatonin and goat embryo papers dominate retrieval.
Economic-security, food-biotechnology, citrus-adjacent and thymosin piglets chips from the prior cloud are dropped.
Open limits
Where is a dedicated Ovagen® pharmacology paper in open full text?
How should goat embryo peptide schemes be linked without claiming product identity?
Human IVF or anovulation adjunct series under this name are not in our map.
Russian full-text papers
Open-access Russian academic PDFs on CyberLeninka where we have them.
svetovoy rezhim anovulyatsiya i risk zlokachestvennyh novoobrazovaniy zhRussian full text
primenenie melatonina v akushersko ginekologicheskoy praktikeRussian full text
effektivnaya shema induktsii poliovulyatsii dlya transplantatsii embrionRussian full text
kriorezistentnost embrionov koz v zavisimosti ot stadii razvitiyaRussian full text
razrabotka effektivnyh shem induktsii poliovulyatsii u molochnyh koz s pRussian full text
variabelnost otveta yaichnikov pri induktsii poliovulyatsii u kozRussian full text
vliyanie polipeptidnyh kompleksov na razvitie organotipicheskoy kulturyRussian full text
sochetannoe vliyanie polipeptidnyh kompleksov na razvitie organotipichesRussian full text
issledovanie biologicheskoy aktivnosti peptidov poluchennyh izvnutrennihRussian full text
lekarstvennye peptidnye preparaty proshloe nastoyaschee buduscheeRussian full text
10 in corpus · off-focus economic security, ageing essays, thymosin piglets, food biotech, bioantioxidant chips removed; broken ovary-culture URL variants kept only when resolvable in prior map
Also on PubMed
No PubMed-indexed rows mapped for this entry in the current corpus.
Still open
Is there a published residue definition for Ovagen?
Do human reproductive-medicine titles ever use the product name as primary intervention?
How does ovarian fraction work relate to pineal light-axis papers without conflating mechanisms?
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.